Kenneth A. Stauderman insider trades
Open-market stock purchases and sales by Kenneth A. Stauderman, Chief Scientific Officer at CalciMedica, Inc, from SEC Form 4 filings since Mar 20, 2023.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -54%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 24, 2026 | CALC CalciMedica, Inc | Bought (not open market) | — |
Companies traded
- CALC CalciMedica, Inc: 2 buys, 1 sale, last Sep 24, 2026
Get free alerts when Kenneth A. Stauderman files a new trade →